<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/13613115-E290-45AC-BAA6-83D88728749C"><gtr:id>13613115-E290-45AC-BAA6-83D88728749C</gtr:id><gtr:name>Xian Jiaotong University</gtr:name><gtr:address><gtr:line1>28 Xianningxi West Road</gtr:line1><gtr:line2>710049</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:department>Inst of Pharmacy and Biomedical Sci</gtr:department><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850"><gtr:id>5BB4F8BF-B4E0-4EAF-9AF5-885E19D64850</gtr:id><gtr:name>University of Strathclyde</gtr:name><gtr:address><gtr:line1>16 Richmond Street</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G1 1XQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/13613115-E290-45AC-BAA6-83D88728749C"><gtr:id>13613115-E290-45AC-BAA6-83D88728749C</gtr:id><gtr:name>Xian Jiaotong University</gtr:name><gtr:address><gtr:line1>28 Xianningxi West Road</gtr:line1><gtr:line2>710049</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>China</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B1173A09-4E27-4BBB-AA1A-60252F0D076F"><gtr:id>B1173A09-4E27-4BBB-AA1A-60252F0D076F</gtr:id><gtr:firstName>Jun</gtr:firstName><gtr:surname>Yu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800173"><gtr:id>D1E2C4D8-44A4-4297-B774-3E10CCB100E9</gtr:id><gtr:title>Genotyping epidemic Shigella sonnei</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800173</gtr:grantReference><gtr:abstractText>Dr. Yu is proposing to carry out further research, in order to combat the Shigella bacteria infection, which affects 160 million people per annum worldwide; resulting in 1.1 million deaths of which most affected are children; under 5 years old. The infection could be so severe; the inflammation in the large intestine and rectum cause bleeding and cramps and patients experience excruciating pains, facing death. To make things worse, most of the epidemic strains are now resistant to all antibiotics available to date. Dr. Yu has carried out extensive research on this subject since 1997 and has been co-authored several important papers on Shigella genome research. His attention is now turning to S. sonnei, which seems to be a real threat to modern civilisation, as it is already very prevalent in developed countries, including those newly industrialised countries such as Republic of China, Thailand, and Iran. To combat the S. sonnei infection, Dr. Yu will investigate the genetic variation among S. sonnei strains of a global collection dated back to 1940s by use of a novel Solexa multiplex sequecing approach and the cutting edge instrument LightCycler 480. It is hoped to find the strain?s origin and route of evolution, how they acquire antibiotic resistance, and in particular, why young children are so susceptible to S. sonnei infection; this life threatening disease. Dr. Yu is confident, that this study will succeed and the new knowledge obtained will help epidemic surveillance, early diagnosis, and treatment and prevention of Shigella infection.</gtr:abstractText><gtr:technicalSummary>Shigella sonnei belongs to the Shigella/EIEC pathovar and has emerged to be the most prevalent species to cause bacillary dysentery in developed countries not only in Europe and North America but also in newly industrialised countries such as Korea, Republic of China, Thailand and Iran. Furthermore, S. sonnei infects more young children (0-5 years old) compared to other species, and most of the epidemic strains are multi-drug resistant due to spread of integrons. S. sonnei contains only one serovar but has many biotypes and their origin and evolution are poorly understood. To combat S. sonnei infection, a novel and effective genotyping scheme is urgently required because current available molecular typing methods have limited discrimination power to reveal global diversity, population genetic structure and evolutionary history of S. sonnei, all of which are important for disease surveillance and epidemiological investigations. Therefore, the proposed project is aimed at (1) development of a single nucleotide polymorphism (SNP)-based multilocus sequence typing (MLST) scheme to type a global S. sonnei collection for explanations as to why S. sonnei is prevalent in developed countries and more susceptible to young children, and to reveal the evolutionary history of this pathogen, and (2) automation of latest Roche LightCycler 480 instrument to detect informative SNPs that mark the current prevalent epidemic phylogenetic groups for S. sonnei surveillance, and (3) construction of a web-based service to facilitate global epidemiologic studies and disseminate new knowledge.</gtr:technicalSummary><gtr:fund><gtr:end>2011-11-10</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-11-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>347380</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Strathclyde Institute of Pharmacy &amp; Biomedical Sciences</gtr:department><gtr:description>SIPBS University of Strathclyde (Dr Veronique Seidel)</gtr:description><gtr:id>ACF3A0CF-0DE4-4FEA-AC53-2ABA575881F1</gtr:id><gtr:impact>Xu D et al., J Med Microbiol. 2011 Nov;60(Pt 11):1626-32.</gtr:impact><gtr:outcomeId>jmw7iXPk985-1</gtr:outcomeId><gtr:piContribution>Dr Seidel has long term interesting in isolation of natural products that exhibit anti-microbial activity. I have initiated conceptually new application of exploiting the natural product; searching for their potential in modulating pathogen-host cell interaction for the benefit of the host.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Xi'an Jiaotong University</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:department>Institute of Immunopathology</gtr:department><gtr:description>Development of Shigella-HPV vaccine (Professor Yili Wang, Xi'an Jiao Tong University China)</gtr:description><gtr:id>258FB3FE-BA55-4767-88C3-2426D14C3870</gtr:id><gtr:impact>For the purpose of vaccine development we have gathered and published the epidemiological and clinical prognosis data of Type 58 HPV in Han population in China (Clinical Oncology 2009. 21: 768e774).

A Chinese PhD student have been working in Strathclyde for 2 years (20010-2011) in constructing the vaccine strains.</gtr:impact><gtr:outcomeId>L4eufuX7MWh-1</gtr:outcomeId><gtr:piContribution>The aim of this collaboration is to develop live attenuated Shigella sonnei carriers which express the L1 proteins from 3 prevalent HPV types16, 18 and 58.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Strathclyde</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Application of gold nano-rods in Biology (Dr Chen, Y., Department of Physics, University of Strathclyde)</gtr:description><gtr:id>70CC075C-4DB6-4BAA-B449-C2C0FD1AA2FA</gtr:id><gtr:impact>We have published one paper (J Biomed Opt. 2010 Mar-Apr;15(2):020504) and recruited a PhD student to carry on the project.</gtr:impact><gtr:outcomeId>QKLJE5PwXss-1</gtr:outcomeId><gtr:partnerContribution>Dr Chen Y and I equally contribute to this potentially productive project, which will lead to a broad spectrum of application of nano-technology in Biology.</gtr:partnerContribution><gtr:piContribution>Dr Chen and I are respectively responsible for Optical Physics and Cell Biology aspects of the project.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SGM symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>8A29C819-9BFD-4FE5-936B-3B129218C8A9</gtr:id><gtr:impact>Over 100 microbiologists were attending the symposium each year.

broader interests in genotyping Shigella sonnei and other pathogenic bacteria were attracted.</gtr:impact><gtr:outcomeId>RRTtTvghMVM</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK-China Bacterial Pathogen Symposium</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>31916A68-F57F-4D6A-B537-5702D2334BF0</gtr:id><gtr:impact>200 professional were present.

interesting discussions were sparked.</gtr:impact><gtr:outcomeId>bxQhALReiqj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>through our genotyping study, it becomes clear that Shigella sonnei is highly diverse in terms of phylogenicity and pathogenicity. In particular some isolates carry virulence plasmid with reduced virulence. Circulation of these less virulent isolates in developed countries may offer natural immunisation to the population</gtr:description><gtr:id>1AE75E87-CB75-4862-92C8-26E0417A4F00</gtr:id><gtr:impact>Further collaborations are initiated among a number of international instiutes.</gtr:impact><gtr:outcomeId>B6DBCE6D754</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>a collection of phylogenetic and pathogenic diverse Shigella sonnei strains.</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A43D10F3-16B5-4A5F-A9AB-337652F50562</gtr:id><gtr:title>Rapid Genotyping of Shigella sonnei by Use of Multiplex High-Resolution Melting.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b4f8c8716df69d4922dc1b34e0fe74f"><gtr:id>9b4f8c8716df69d4922dc1b34e0fe74f</gtr:id><gtr:otherNames>Mazi W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>56cb1336505541.25170128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C257F09-CEF9-4C7F-AB73-F99357679CC4</gtr:id><gtr:title>Draft genome of a Brazilian avian-pathogenic Escherichia coli strain and in silico characterization of virulence-related genes.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e055dcf1e6acb28c330344b0a233a223"><gtr:id>e055dcf1e6acb28c330344b0a233a223</gtr:id><gtr:otherNames>Rojas TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>pm_14804_24_22582380</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DEB0066-05D1-4ABF-B50E-32833692E6CB</gtr:id><gtr:title>Global phylogeny of Shigella sonnei strains from limited single nucleotide polymorphisms (SNPs) and development of a rapid and cost-effective SNP-typing scheme for strain identification by high-resolution melting analysis.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd8c475e989607ea0ea17a366a282dc4"><gtr:id>fd8c475e989607ea0ea17a366a282dc4</gtr:id><gtr:otherNames>Sangal V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>nzKcjRuTrYB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2637FBF8-994F-4D19-ACC7-89101A803C6B</gtr:id><gtr:title>Natural products modulate Shigella-host-cell interaction.</gtr:title><gtr:parentPublicationTitle>Journal of medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2615</gtr:issn><gtr:outcomeId>ejCthQ7xzTf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84D91F91-C740-48A3-A079-9A4E1D686C3D</gtr:id><gtr:title>Prevalence of integrons in Shigella sonnei from Brazil.</gtr:title><gtr:parentPublicationTitle>The Journal of antibiotics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a5af0e7542bcb6504b198281304155e"><gtr:id>3a5af0e7542bcb6504b198281304155e</gtr:id><gtr:otherNames>Yu J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-8820</gtr:issn><gtr:outcomeId>b8DT82pTcGg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2AE1DC7-83C8-4B5E-8496-F77E5CC68882</gtr:id><gtr:title>Impacts of a long-term programme of active surveillance and chlorhexidine baths on the clinical and molecular epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in an Intensive Care Unit in Scotland.</gtr:title><gtr:parentPublicationTitle>International journal of antimicrobial agents</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd8c475e989607ea0ea17a366a282dc4"><gtr:id>fd8c475e989607ea0ea17a366a282dc4</gtr:id><gtr:otherNames>Sangal V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0924-8579</gtr:issn><gtr:outcomeId>pm_14804_24_22871372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9BAE478-94A8-4071-8982-B11A65960419</gtr:id><gtr:title>Shigella sonnei genome sequencing and phylogenetic analysis indicate recent global dissemination from Europe.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9caa2c3f48073eb3bcf0c6e1f2fcff3"><gtr:id>e9caa2c3f48073eb3bcf0c6e1f2fcff3</gtr:id><gtr:otherNames>Holt KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14804_24_22863732</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800173</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>